PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 1, 2024European Heart Journal - Case ReportsOpen Access

An unusual complication after transcatheter aortic valve implantation: a case report

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Ventricular septal defect is an unusual complication of TAVI whose risk factors are not well understood, and percutaneous treatment remains challenging.

Population

An 80-year-old woman with bioprosthesis degeneration and severe intraprosthetic aortic regurgitation

Design

Case report

Authors

AMAlba Abril MolinaMQMónica Fernández QueroJHJosé Eduardo López Haldón

Discussion

Loading...

Member takes

Overview

Supports percutaneous VSD closure feasibility after complex TAVI; leaves open optimal risk stratification and prevention strategies.

Structured PICO

P
Population
An 80-year-old woman with two previous surgical aortic valve replacements admitted for decompensated heart failure due to bioprosthesis degeneration with severe intraprosthetic aortic regurgitation (n=1).
I
Intervention
Valve-in-valve TAVI with chimney stenting of both coronary arteries, using a 23 mm self-expandable valve, followed by bioprosthetic valve fracture.
O
Outcome
Iatrogenic ventricular septal defect (VSD) during valve fracture, followed by severe haemolytic anaemia and heart failure requiring percutaneous closure.safety

Bioprosthetic valve fracture during valve-in-valve TAVI can lead to iatrogenic ventricular septal defect, which may require percutaneous closure if symptomatic.

Cite This Study

Molina et al. (2024) studied this question.

synapsesocial.com/papers/6a70ab27439bab0cabc34498https://doi.org/10.1093/ehjcr/ytae045
View Full Paper
Ask AI
Bookmark
Share